psychedelics investing Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology
psychedelics investing Quarterly Activities Report: Melodiol Delivers $9.3m in Revenue During H1 FY24 – a 33% Increase the PCP
psychedelics investing $12M Proposed Cash Asset Sale to Strengthen Balance Sheet, with $2.2M of Earn Outs
psychedelics investing Emyria Selected by Reach Wellness to Lead MDMA -Assisted Therapy Research for First Responders
Centurion to Resume Trading and Provides Update on Option to Acquire the Brothers Gold Project, Suriname
Equity Metals Files Technical Report on Silver Queen Project with Significant Increase in Ag-Au-Zn Mineral Resources
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
